These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15390237)

  • 1. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.
    Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.
    Martin JL; Pratsos A; Magargee E; Mayhew K; Pensyl C; Nunn M; Day F; Shapiro T
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):1-5. PubMed ID: 18098171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions.
    Rickli H; Unterweger M; Sütsch G; Brunner-La Rocca HP; Sagmeister M; Ammann P; Amann FW
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):297-302. PubMed ID: 12410501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.
    Azmoon S; Pucillo AL; Aronow WS; Ebrahimi R; Vozzolo J; Rajdev A; Kalapatapu K; Ro JH; Hjemdahl-Monsen C
    J Invasive Cardiol; 2010 Apr; 22(4):175-8. PubMed ID: 20351388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and effectiveness of a novel vascular hemostatic device (Chula-clamp) after coronary angiography or percutaneous coronary intervention.
    Plainetr V; Itsathitpaisam W; Chaipromprasit J; Srimahachota S; Sukseree Y; Songmuang SB
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S180-8. PubMed ID: 17718286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial.
    Chevalier B; Lancelin B; Koning R; Henry M; Gommeaux A; Pilliere R; Elbaz M; Lefevre T; Boughalem K; Marco J; Dupouy P;
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):285-91. PubMed ID: 12594688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial].
    Magosaki N; Hosoda S; Kawagishi N; Yamaguchi T; Sakatani H; Haze K; Itagane H; Otsuka M; Nobuyoshi M; Yokoi H
    J Cardiol; 1999 Sep; 34(3):131-8. PubMed ID: 10500973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid hemostasis of arterial puncture sites with Angio-Seal in patients undergoing percutaneous coronary intervention.
    Trisnohadi HB
    Acta Med Indones; 2005; 37(2):87-90. PubMed ID: 20066791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial.
    Nasu K; Tsuchikane E; Sumitsuji S;
    J Invasive Cardiol; 2003 May; 15(5):251-6. PubMed ID: 12730632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular complications with newer generations of angioseal vascular closure devices.
    Applegate RJ; Sacrinty M; Kutcher MA; Gandhi SK; Baki TT; Santos RM; Little WC
    J Interv Cardiol; 2006 Feb; 19(1):67-74. PubMed ID: 16483343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty.
    Noguchi T; Miyazaki S; Yasuda S; Baba T; Sumida H; Morii I; Daikoku S; Goto Y; Nonogi H
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):451-5. PubMed ID: 10828223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of FemoStop system for arterial puncture site closure after coronary angioplasty.
    Kunert M; Gremmler B; Schleiting H; Ulbricht LJ
    J Invasive Cardiol; 2004 May; 16(5):240-2. PubMed ID: 15152127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression.
    Deuling JH; Vermeulen RP; Anthonio RA; van den Heuvel AF; Jaarsma T; Jessurun G; de Smet BJ; Tan ES; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):518-23. PubMed ID: 18307223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study.
    Veasey RA; Large JK; Silberbauer J; Paul G; Taggu W; Ellery S; Rathore VS; Lloyd GW; Patel NR; Sulke AN
    Int J Clin Pract; 2008 Jun; 62(6):912-8. PubMed ID: 18479284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention.
    Narins CR; Zareba W; Rocco V; McNitt S
    J Invasive Cardiol; 2008 Nov; 20(11):579-84. PubMed ID: 18987396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.
    Bavry AA; Raymond RE; Bhatt DL; Chambers CE; DeNardo AJ; Hermiller JB; Myers PR; Pitts DE; Scott JA; Savader SJ; Steinhubl S
    J Invasive Cardiol; 2008 Apr; 20(4):152-6. PubMed ID: 18398227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of "pre-closure" utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) Trial.
    Nasu K; Tsuchikane E; Sumitsuji S; Tsuji T; Tamai H
    J Invasive Cardiol; 2005 Jan; 17(1):30-3. PubMed ID: 15640537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.